Related Experiment Video
Updated: Jun 27, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction
F J Van de Werf1, E J Topol, B E Sobel
1Department of Cardiology, University Hospitals Leuven, Leuven, Belgium. frans.vandewerf@uz.kuleuven.ac.be
As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue-plasminogen activator (t-PA) more particularly and the current indications for its use in the era of mechanical reperfusion.
As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue-plasminogen activator (t-PA) more particularly and the current indications for its use in the era of mechanical reperfusion.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

